Concepedia

Publication | Open Access

Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors

33

Citations

14

References

2023

Year

Abstract

NCT02947165.

References

YearCitations

Page 1